Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026)
Achieve Life Sciences (ACHV) posted Retained Earnings of -$270.4 million for Q1 2026, down 2704040.0% on a QoQ basis from $10000.0 in Q4 2025, and down 4506666.67% year-over-year from N/an in Q1 2025.
Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$270.4 million for Q1 2026.
- Quarterly Retained Earnings fell 4506666.67% year-over-year to -$270.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$270.4 million (down 4506666.67% YoY) and the FY2025 annual result came in at $10000.0, down 67.74% from the prior year.
- Retained Earnings was -$270.4 million for Q1 2026 at Achieve Life Sciences, down from $10000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $31000.0 in Q4 2024 and bottomed at -$270.4 million in Q1 2026.
- A 5-year average of -$88.0 million and a median of -$101.2 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 100.02% in 2024, while the deepest fall reached 4830550.0% in 2024.
- Achieve Life Sciences' Retained Earnings stood at $4000.0 in 2022, then slumped by 4143875.0% to -$165.8 million in 2023, then soared by 100.02% to $31000.0 in 2024, then sank by 67.74% to $10000.0 in 2025, then tumbled by 2704040.0% to -$270.4 million in 2026.
- Business Quant data shows ACHV's Retained Earnings at -$270.4 million in Q1 2026, $10000.0 in Q4 2025, and $9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | -270.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -270.39 Mn |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | -231.12 Mn |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | -193.22 Mn |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | -165.75 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | -153.17 Mn |
| Mar 31, 2023 | -144.90 Mn |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | -124.70 Mn |
| Jun 30, 2022 | -111.60 Mn |
| Mar 31, 2022 | -101.20 Mn |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | -79.70 Mn |